PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'German Institute for Drug Use Evaluation (DAPI), Berlin, Germany.\', \'Department of Internal Medicine III - Cardiology, Angiology and Intensive Care Medicine, Saarland University Medical Center, Homburg, Germany.\', \'Department of Cardiology, University Hospital Leipzig, Leipzig, Germany.\', \'Drug Commission of German Pharmacists (AMK), Berlin, Germany.\', \'Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/pds.5324
?:doi
?:hasPublicationType
?:journal
  • Pharmacoepidemiology and drug safety
is ?:pmid of
?:pmid
?:pmid
  • 34245078
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.329
?:rankingScore_hIndex
  • 80
?:title
  • Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34245078>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34245078>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all